authors

• Sklepinski, Stacey M
• Mickelson, Mindy M
• McCoy, Rozalina G
• Herrin, Jeph
• Swarna, Kavya Sindhu
• Neumiller, Joshua J
• Galindo, Rodolfo J
• Umpierrez, Guillermo E
• Joseph S. Ross, MD, MHS
• Deng, Yihong
• Polley, Eric C

publication date

• August 17, 2026

published in

• Diabetes research and clinical practice  Journal

has subject area

• Aged
• Diabetes Mellitus, Type 2
• Dipeptidyl-Peptidase IV Inhibitors
• Female
• Glucagon-Like Peptide-1 Receptor Agonists
• Humans
• Hypoglycemic Agents
• Incidence
• Insulin Secretagogues
• Male
• Middle Aged
• Neoplasms
• Sodium-Glucose Transporter 2 Inhibitors
• Sulfonylurea Compounds

Keywords

• Cancer
• Dipeptidyl-peptidase 4 inhibitors
• Glucagon-like peptide-1 receptor agonists
• Sodium-glucose transporter 2 inhibitors
• Sulfonylureas
• Type 2 diabetes

Digital Object Identifier (DOI)

• https://doi.org/10.1016/j.diabres.2026.113503

PubMed ID

• 42607727

start page

end page